Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlægerne i Møllegade ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5%   Bankruptcy risk   1.9% 1.4% 1.4% 1.3% 1.2% 2.3% 6.1% 6.1%   Credit score (0-100)   71 80 78 79 82 63 38 38   Credit rating   A A A A A BBB BBB BBB   Credit limit (kDKK)   1.8 88.9 69.5 145.5 327.5 0.1 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   6,292 6,694 6,878 8,229 10,786 12,923 0.0 0.0   EBITDA   1,004 1,128 1,258 1,423 2,354 926 0.0 0.0   EBIT   353 486 625 958 1,748 61.0 0.0 0.0   Pre-tax profit (PTP)   295.3 414.5 588.3 940.8 1,832.0 32.2 0.0 0.0   Net earnings   228.6 320.8 458.7 739.1 1,426.4 24.2 0.0 0.0   Pre-tax profit without non-rec. items   295 414 588 941 1,832 32.2 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   6,970 6,789 6,433 127 940 890 0.0 0.0   Shareholders equity total   7,566 7,587 7,545 7,785 8,711 3,735 3,685 3,685   Interest-bearing liabilities   2,683 2,528 2,353 184 3,096 2,609 0.0 0.0   Balance sheet total (assets)   11,921 11,491 11,814 9,628 13,331 7,888 3,685 3,685   Net Debt   1,761 1,931 14.9 -1,581 1,793 1,087 -388 -388     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   6,292 6,694 6,878 8,229 10,786 12,923 0.0 0.0   Gross profit growth   -3.8% 6.4% 2.8% 19.6% 31.1% 19.8% -100.0% 0.0%   Employees   10 10 10 10 12 15 0 0   Employee growth %   11.1% 0.0% 0.0% 0.0% 20.0% 25.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   11,921 11,491 11,814 9,628 13,331 7,888 3,685 3,685   Balance sheet change%   -2.1% -3.6% 2.8% -18.5% 38.5% -40.8% -53.3% 0.0%   Added value   1,003.6 1,128.5 1,258.1 1,422.7 2,212.1 926.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -1,301 -1,223 -1,390 -7,170 2,146 -1,557 -890 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   5.6% 7.3% 9.1% 11.6% 16.2% 0.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   3.0% 4.3% 5.6% 9.4% 17.0% 2.4% 0.0% 0.0%   ROI %   3.2% 4.6% 6.1% 10.7% 18.9% 2.6% 0.0% 0.0%   ROE %   3.0% 4.2% 6.1% 9.6% 17.3% 0.4% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   63.5% 66.0% 63.9% 80.9% 65.3% 47.6% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   175.5% 171.1% 1.2% -111.1% 76.2% 117.4% 0.0% 0.0%   Gearing %   35.5% 33.3% 31.2% 2.4% 35.5% 69.8% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   2.2% 3.4% 2.5% 5.4% 7.1% 7.7% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.6 2.3 1.8 5.1 6.8 2.1 0.0 0.0   Current Ratio   1.7 2.3 1.9 5.2 7.0 2.1 0.0 0.0   Cash and cash equivalent   922.0 596.5 2,338.3 1,765.5 1,302.5 1,521.2 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   711.6 1,091.4 1,410.3 5,990.6 7,115.7 1,883.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   100 113 126 142 184 62 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   100 113 126 142 196 62 0 0   EBIT / employee   35 49 63 96 146 4 0 0   Net earnings / employee   23 32 46 74 119 2 0 0